Safety and Manufacturing Standards
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2001
Volume 25
Issue 10
FDA may adopt new requirements to enhance the safe use of pharmaceuticals and ensure that all US drugs are available when needed.
Articles in this issue
Outsourcing Outlook
Effects of Polyethylene Glycol on Morphology, Thermomechanical Properties, and Water Vapor Permeability of Cellulose Acetate-Free Films
Hydrogels for the Controlled Release of Pharmaceutical Proteins
Near-Infrared Inspection Complements Other QC Systems
Safety and Manufacturing Standards
System Optimization for In Situ Fiber-Optic Dissolution Testing: Hydrodynamic Effects, System Performance, and Applications
Current Status of the Oral Delivery of Insulin
Laboratory Equipment Qualification
Filter Integrity Testing in Liquid Applications, Revisited, Part I
360° Feedback - Improving the Selection Process All the Way Around
Entering into an Alliance with Big Pharma: Benchmarks for Drug Delivery Contract Service Providers
Recent Videos
A CDMO’s Role in API Quality
Ask the Expert: Quality Control Units
Industry Outlook 2025: European Geopolitical Impact on Pharma
Industry Outlook 2025: Political Implications for Pharma
Ask the Expert: EU Data Protection
Industry Outlook 2025: The Impact of Politics on Pharma
Industry Outlook 2025: Technology as a Supporting Element
Tariff Pause Reinforces Uncertainty Among Biopharma Professionals
Industry Outlook 2025: Talent Up for Grabs
INTERPHEX 2025: ‘Breaking Up the Octopus’ of Single-Use Systems
Related Content
Guidance on Quality Culture Standards
June 3rd 2025Article
Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.
